ArticleOncoimmunology2014

Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.

Marvin M van Luijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.